Abbott Laboratories Scores 75% on Multi-Factor Investor Model

A recent report highlights Abbott Laboratories' performance according to the Multi-Factor Investor model, indicating a solid position with a score of 75%. This score suggests investor interest, although it falls short of indicating strong enthusiasm.

Date: 12-11-2024

AI Rating: 6

Abbott Laboratories (ABT) has recently been evaluated through the Multi-Factor Investor model, achieving a commendable score of 75%. This score is indicative of the company's underlying fundamentals and overall stock valuation. A score of 80% or more typically reflects a degree of investor interest, while scores above 90% indicate strong investor enthusiasm.

The report indicates that Abbott has passed several critical tests within the multi-factor strategy criteria. Notably, the company passed the Market Cap and Standard Deviation tests, which suggests stability in market presence and lower volatility, respectively. However, the company's performance in Twelve Minus One Momentum and Net Payout Yield was classified as neutral, indicating neither strong momentum nor a compelling payout yield at this time.

Despite the overall positive score, the company did not achieve the highest rating, as indicated by the Final Rank which resulted in a failure classification. This may signal to investors that while Abbott shows potential, there are areas that need improvement to elevate the stock's attractiveness significantly.

Stocks: ABT